Committee for Advanced Therapies (CAT): 12-14 September 2018

EventHumanAdvanced therapiesInnovation

Date

Wednesday, 12 September 2018, All day

Location

European Medicines Agency, Amsterdam, the Netherlands

The Committee for Advanced Therapies is responsible for assessing the quality, safety and efficacy of advanced-therapy medicines, including medicines classified as gene-therapy, somatic-cell-therapy or tissue-engineered products. Abbreviated as CAT. For more information, see Committee for Advanced Therapies (CAT). (CAT) is the committee that is responsible for assessing the quality, safety and efficacy of advanced-therapy medicines.

Documents

Share this page